Live feed
Filing
SC 13G/A
SC 13G/A0000902219-21-000383·Sage Therapeutics, Inc.
Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 78667J108
Event date: 2021-07-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,126,680
- Percent of class
- 10.4800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-21-000383
- Form type
- SC 13G/A
- Filer
- Sage Therapeutics, Inc.
- CIK
- CIK 1597553
- Filed
- Aug 10, 2021
- Reporting period
- Jul 30, 2021
- Description
- Schedule 13G beneficial ownership